Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Background: Patients (pts) with esophageal/ gastro-esophageal junction (GOJ) adenocarcinoma (EAC) who do not show early metabolic response (as defined by 18-FDG PET) to chemotherapy have poorer survival and histological response rates <5%. We investigate if, by tailoring the neoadjuvant therapy, histological response can be improved in pts not showing early metabolic response after the first cycle of treatment.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.